pharmalittle
Pharmalittle is a newsletter is written by Ed Silverman, a veteran health care journalist who has covered the industry for more than 20 years. Silverman’s reporting focuses on the latest news and trends in the pharmaceutical industry, including drug development, drug pricing, and the impact of the industry on patients and society.
Most Read
STAT Plus: Pharmalittle: A ‘King Kong’ of weight-loss drugs is looming; FTC orders Illumina to divest Grail
STAT Plus: Pharmalittle: FDA approvals will stop if U.S. defaults on its debts; DEA failed to punish wholesaler blamed in opioid crisis
STAT Plus: Pharmalittle: Appellate judges appear skeptical of FDA decisions on abortion pill; FTC widens probe into PBMs
STAT Plus: Pharmalittle: Online prescribing prompts scrutiny and concern; FDA is pushed to approve OTC birth control pills
STAT Plus: Pharmalittle: Weight-loss drug makers lobby Congress for Medicare coverage; Europe braces for new pharma legislation
STAT Plus: Pharmalittle: Novartis boosts its sales and profit outlook; Biogen trims its drug pipeline
STAT Plus: Pharmalittle: FDA OKs new kind of drug to treat hot flashes; Alzheimer’s drug could cost Medicare up to $5 billion a year
All Coverage
advertisement